8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Improving Patient Care: Consequences for Resource Allocation

      review-article
      Cardiology
      S. Karger AG
      Heart failure, Economic evaluation, Postinfarction prophylaxis, Hypertension

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clinical trials have been designed to document the safety and efficacy of therapeutic interventions. However, data on the cost-effectiveness of new treatment regimens are increasingly required. This paper reviews economic evaluations performed on clinical trials in 3 different therapeutic areas: postinfarction prophylaxis, hypertension and heart failure. The data demonstrate that economic evaluations can provide important information which will aid decision making with respect to the cost-effectiveness of new treatment regimens. It is suggested that health economists and clinicians must work together to ensure that the limited health care budget is utilised to optimum effect.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1994
          1994
          18 November 2008
          : 84
          : 6
          : 420-426
          Affiliations
          Stockholm School of Economics, Stockholm, Sweden
          Article
          176434 Cardiology 1994;84:420–426
          10.1159/000176434
          8062308
          4db931fd-4b9b-48f9-8ad3-a8b431e3b4b7
          © 1994 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 7
          Categories
          Trials for Life: The Influence of Mortality Trials on the Evolution of Clinical Practice

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Heart failure,Hypertension,Economic evaluation,Postinfarction prophylaxis

          Comments

          Comment on this article